# Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

> **NCT06173219** · PHASE1,PHASE2 · RECRUITING · sponsor: **China-Japan Friendship Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **COMBINATION_PRODUCT:** Radiotherapy combined with immunotherapy

## Key facts

- **NCT ID:** NCT06173219
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06173219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06173219, "Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06173219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*